SHAREHOLDER ALERT: Holzer & Holzer Announces that a Class Action Was Filed on Behalf of Root, Inc. Investors and Encourages Investors With Significant Losses to Contact the Firm
Atlanta, Georgia--(Newsfile Corp. - March 22, 2021) - Holzer & Holzer, LLC announces that a class action lawsuit has been filed on behalf of investors who purchased Root, Inc. ("Root" or the "Company") (NASDAQ: ROOT) securities between October 28, 2020 and March 8, 2021, inclusive (the "Class Period"). The complaint alleges throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Root would foreseeably fail to generate positive cash...
2021-03-22 4:03 PM EDT
SHAREHOLDER ALERT: Investigation of AgEagle Aerial Systems, Inc. Announced by Holzer & Holzer, LLC
Atlanta, Georgia--(Newsfile Corp. - February 18, 2021) - Holzer & Holzer, LLC is investigating whether AgEagle Aerial Systems, Inc. ("AgEagle or the "Company") (NYSE: UAVS) complied with federal securities laws. On February 18, 2021, Bonitas Research published a report stating that "in April 2020 rumor of a partnership between Amazon.com, Inc. & AgEagle was started by a promotional video uploaded to AgEagle's founder and former chairman Bret Chilcott's daughter's personal website and youtube...
2021-02-18 5:10 PM EST
SHAREHOLDER ALERT: Holzer & Holzer Announces that a Class Action Was Filed on Behalf of EHang Investors and Encourages Investors With Significant Losses to Contact the Firm
Atlanta, Georgia--(Newsfile Corp. - February 17, 2021) - Holzer & Holzer, LLC announces that a class action lawsuit has been filed on behalf of investors who purchased EHang Holdings Limited ("EHang" or the "Company") (NASDAQ: EH) American depositary shares ("ADS") between December 12, 2019 and February 16, 2021, inclusive (the "Class Period"). The complaint alleges throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the Company's...
2021-02-17 7:30 PM EST
SHAREHOLDER ALERT: Investigation of Jianpu Announced by Holzer & Holzer, LLC
Atlanta, Georgia--(Newsfile Corp. - February 17, 2021) - Holzer & Holzer, LLC is investigating whether Jianpu Technology Inc. (NYSE: JT) ("Jianpu or the "Company") complied with federal securities laws. On February 16, 2021, Jianpu announced the results of a review by the independent audit committee members of its board of directors, which found "certain transactions involved third-party agents (including both upstream agents and downstream suppliers) with undisclosed relationships, and some...
2021-02-17 12:38 PM EST
SHAREHOLDER ALERT: Investigation of EHang Announced by Holzer & Holzer, LLC
Atlanta, Georgia--(Newsfile Corp. - February 16, 2021) - Holzer & Holzer, LLC is investigating whether EHang Holdings Limited ("EHang" or the "Company") (NASDAQ: EH) complied with federal securities laws. On Feburary 16, 2021, Wolfpack Research published a report claiming to have evidence that the Company is "built on largely fabricated revenues based on sham sales contracts." The price of EHang's stock fell following the announcement. If you purchased shares of EHang and suffered a loss on...
2021-02-16 6:05 PM EST
SHAREHOLDER ALERT: Holzer & Holzer Announces that a Class Action Was Filed on Behalf of bluebird bio Investors and Encourages Investors With Significant Losses to Contact the Firm
Atlanta, Georgia--(Newsfile Corp. - February 16, 2021) - Holzer & Holzer, LLC announces that a class action lawsuit has been filed on behalf of investors who purchased bluebird bio, Inc. ("bluebird bio" or the "Company") (NASDAQ: BLUE) securities between May 11, 2020 and November 4, 2020, inclusive (the "Class Period"). The complaint alleges throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) data supporting bluebird's BLA...
2021-02-16 7:00 AM EST
SHAREHOLDER ALERT: Investigation of Cellcom Israel Announced by Holzer & Holzer, LLC
Atlanta, Georgia--(Newsfile Corp. - February 8, 2021) - Holzer & Holzer, LLC is investigating whether Cellcom Israel Ltd. ("Cellcom Israel" or the "Company") (NYSE: CEL) complied with federal securities laws. On January 31, 2021, Cellcom Israel announced that Marathon 018 Xfone Ltd., the Company's cellular sharing network partner, had sent Cellcom Israel an annulment notice of the two companies' sharing agreement, "alleging that [Cellcom Israel] has materially breached the sharing agreement...
2021-02-08 12:30 AM EST
SHAREHOLDER ALERT: Investigation of Clover Health Investments Announced by Holzer & Holzer, LLC
Atlanta, Georgia--(Newsfile Corp. - February 4, 2021) - Holzer & Holzer, LLC is investigating whether Clover Health Investments, Corp. ("Clover" or the "Company") (NASDAQ: CLOV) complied with federal securities laws. On February 4, 2021, Hindenburg Research published a report stating that it had obtained a copy of a DOJ Civil Investigative Report seeking testimony in connection with an investigation into "whether Clover Health Investment Corporation and/or related entities improperly induced...
2021-02-04 10:27 AM EST
SHAREHOLDER ALERT: Investigation of Immunovant Announced by Holzer & Holzer, LLC
Atlanta, Georgia--(Newsfile Corp. - February 2, 2021) - Holzer & Holzer, LLC is investigating whether Immunovant, Inc. (NASDAQ: IMVT) ("Immunovant" or the "Company") complied with federal securities laws. On February 2, 2021, the Company announced it had decided to voluntarily pause dosing in ongoing clinical studies in both Thyroid Eye Disease and Warm Autoimmune Hemolytic Anemia after it had "become aware of a physiological signal consisting of elevated total cholesterol and LDL levels in...
2021-02-02 12:32 PM EST
SHAREHOLDER ALERT: Investigation of iRhythm Announced by Holzer & Holzer, LLC
Atlanta, Georgia--(Newsfile Corp. - January 29, 2021) - Holzer & Holzer, LLC is investigating whether iRhythm Technologies, Inc. ("iRhythm" or the "Company") (NASDAQ: IRTC) complied with federal securities laws. On January 29, 2021, a Baird research analyst indicated that Novartis, a Medicare Administrative Contractor, reimbursement rates concerning heart monitors are "way lower than" those published in the Medicare Physician Fee Schedule. The price of iRhythm's stock fell following the...
2021-01-29 3:14 PM EST
SHAREHOLDER ALERT: Investigation of Ocugen Announced by Holzer & Holzer, LLC
Atlanta, Georgia--(Newsfile Corp. - January 25, 2021) - Holzer & Holzer, LLC is investigating whether Ocugen, Inc. ("Ocugen" or the "Company") (NASDAQ: OCGN) complied with federal securities laws. On January 12, 2021, Ocugen announced the cancellation of a Company stockholder meeting for the following day and plans to re-evaluate the details of a proposed increase in the number of shares of common stock "in light of the recent potential addition of COVAXIN™ to its pipeline as well as its...
2021-01-25 3:04 PM EST
SHAREHOLDER ALERT: Investigation of Eos Announced by Holzer & Holzer, LLC
Atlanta, Georgia--(Newsfile Corp. - January 25, 2021) - Holzer & Holzer, LLC is investigating whether Eos Energy Enterprises, Inc. ("Eos" or the "Company") (NASDAQ: EOSE) complied with federal securities laws. On January 14, 2021, analyst Iceberg Research published a report entitled "Eos Energy ($EOSE): Fake Customers Won't Recharge a Dead Battery" asserting that Eos is a battery energy storage systems special purpose acquisition company with "failed technology and dubious customers." The...
2021-01-25 2:53 PM EST
SHAREHOLDER ALERT: Holzer & Holzer Announces that a Class Action Was Filed on Behalf of Voyager Therapeutics Investors and Encourages Investors With Significant Losses to Contact the Firm
Atlanta, Georgia--(Newsfile Corp. - January 25, 2021) - Holzer & Holzer, LLC announces that a class action lawsuit has been filed on behalf of investors who purchased Voyager Therapeutics, Inc. ("Voyager" or the "Company") (NASDAQ: VYGR) securities between June 1, 2017 and November 9, 2020, inclusive (the "Class Period"). The complaint alleges throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company's VY-HTT01 IND...
2021-01-25 2:51 PM EST
SHAREHOLDER ALERT: Investigation of Neoleukin Therapeutics Announced by Holzer & Holzer, LLC
Atlanta, Georgia--(Newsfile Corp. - January 25, 2021) - Holzer & Holzer, LLC is investigating whether Neoleukin Therapeutics, Inc. (NASDAQ: NLTX) ("Neoleukin" or the "Company") complied with federal securities laws. On January 8, 2021, Neoleukin announced that "on January 7, 2021, it received a clinical hold letter from the U.S. Food and Drug Administration (FDA) related to its Investigational New Drug (IND) Application to begin a Phase 1 clinical program of its immunotherapeutic candidate,...
2021-01-25 2:49 PM EST
SHAREHOLDER ALERT: Holzer & Holzer Announces that a Class Action Was Filed on Behalf of Lizhi Investors and Encourages Investors With Significant Losses to Contact the Firm
Atlanta, Georgia--(Newsfile Corp. - January 21, 2021) - Holzer & Holzer, LLC announces that a class action lawsuit has been filed on behalf of investors who purchased Lizhi, Inc. (NASDAQ: LIZI) ("Lizhi" or the "Company") securities traceable to the Company's January 17, 2020 initial public offering (the "IPO"). The complaint alleges defendants made false and/or misleading statements and/or failed to disclose that: (1) at the time of the IPO, the coronavirus was already spreading in China, the...
2021-01-21 9:40 AM EST
SHAREHOLDER ALERT: Investigation of bluebird Announced by Holzer & Holzer, LLC
Atlanta, Georgia--(Newsfile Corp. - November 11, 2020) - Holzer & Holzer, LLC is investigating whether bluebird bio, Inc. ("bluebird" or the "Company") (NASDAQ: BLUE) complied with federal securities laws. On November 4, 2020, the Company announced its submission to the FDA for approval of its bb1111 product will be delayed until late 2022. The price of bluebird's stock fell following the announcement. If you purchased shares of bluebird and suffered a loss on that investment, you are...
2020-11-11 10:04 AM EST
SHAREHOLDER ALERT: Investigation of Biogen Announced by Holzer & Holzer, LLC
Atlanta, Georgia--(Newsfile Corp. - November 11, 2020) - Holzer & Holzer, LLC is investigating whether Biogen Inc. (NASDAQ: BIIB) ("Biogen" or the "Company") complied with federal securities laws. Trading in Biogen was halted on November 6, 2020, in advance of the Company's meeting with the FDA. On the same day, Bloomberg reported in an article titled "Biogen Alzheimer's Drug Fails to Gain FDA Panel's Backing," that "the outside experts voted 8 to 1, with 2 undecided, that data from a single...
2020-11-11 10:01 AM EST
SHAREHOLDER ALERT: Investigation of Columbia Sportswear Announced by Holzer & Holzer, LLC
Atlanta, Georgia--(Newsfile Corp. - November 4, 2020) - Holzer & Holzer, LLC is investigating whether Columbia Sportswear Company (NASDAQ: COLM) ("Columbia Sportswear" or the "Company") complied with federal securities laws. On October 29, 2020, the Company announced its third quarter 2020 financial results and disclosed a 23% decline in net sales partly due to "approximately $45 million of Fall 2020 shipments shifting into fourth quarter 2020." The price of Columbia Sportswear's stock fell...
2020-11-04 3:40 PM EST
SHAREHOLDER ALERT: Investigation of Neovasc Announced by Holzer & Holzer, LLC
Atlanta, Georgia--(Newsfile Corp. - November 3, 2020) - Holzer & Holzer, LLC is investigating whether Neovasc Inc. (NASDAQ: NVCN) ("Neovasc" or the "Company") complied with federal securities laws. On October 28, 2020, the Company announced that the FDA voted on its Neovasc Reducer and found against issuing a reasonable assurance of effectiveness and against whether the benefits outweigh the relative risks. The price of Neovasc's stock fell following the announcement. If you purchased shares...
2020-11-03 9:36 AM EST
SHAREHOLDER ALERT: Investigation of SAP Announced by Holzer & Holzer, LLC
Atlanta, Georgia--(Newsfile Corp. - November 3, 2020) - Holzer & Holzer, LLC is investigating whether SAP SE (NYSE: SAP) ("SAP" or the "Company") complied with federal securities laws. On October 25, 2020, the Company announced it's third quarter 2020 financial results and lowered its full year 2020 outlook. The price of SAP's stock fell following the announcement. If you purchased shares of SAP and suffered a loss on that investment, you are encouraged to contact Corey D. Holzer, Esq. at...
2020-11-03 9:33 AM EST